Age-related macular degeneration (AMD) is an eye disease affecting mainly the older generation.

Contributors to the Health System and Policy Monitor met in Riga at the end of October

How is treatment of glaucoma financed in Slovakia?

Peter reviewed analytical paper written by the Institute for Healthcare Analyses on the provision of health care to refugees from Ukraine.

Take a look on our new report on Good practices in financing healthcare services in ophthalmology

Peter presented the Czech health care system to students of the MBA program from Loyola University Chicago.

Our collection of short studies dedicated to different healthcare related topics was published.

AmCham Slovakia brought together stakeholders and started a debate about the need to create a national prevention program.

In study, we analyse excess mortality in the Slovak Republic during the COVID-19 pandemic.  

On September 29, the Slovak Health Care conference was held under the auspices of Zdravotnícky noviny.  Peter Pažitný took part in the debate, which was dominated by the topic of financial resources in the health sector.

Wa have prepared a study on the topic of drug policy in Slovakia in a broader budgetary context. In the study, we explain the functioning of regulatory instruments, name the problematic issues of the current system set-up and present different views of stakeholders on the issue.

Slovak healthcare in the post-covid era: 2020-2025-2030

Peter Pažitný is a signatory of the expert opinion on the Recovery and Resilience Plan & the National and Integrated Reform Plan, which was created as an initiative of the AMCHAM health section.

As part of the project of the Conservative Institute - Tearing down the myths about socialism and welfare state, we published two texts

Peter Pažitný, Daniela Kandilaki and Ľubica Löffler participated in the research that was measuring the availability of selected health services in Slovakia using a new method - Vignette Methodology.  

In his article for Health newspaper, Peter expresses his opinion on cross-ownership.  

Daniela successfully defended her PhD thesis at the Faculty of Management of the University of Economics in Prague.  

This year's scientific conference on Pharmacoeconomics in Slovakia XXXVII also focused on management, economics and health technologies. In his lecture, Peter Pažitný focused on the topic "Managerial tools, incentives and regulations in the context of the achievement of the private and social objectives of the Slovak Health Care System".

Peter has further developed his successful academic career by being awarded the title of Associate Professor at the Faculty of Management of the University of Economics in Prague.

In June 2018, Peter Pažitný and the former Minister of health Rudolf Zajac have prepared a study to help the Armenian government with the reform of its health insurance system. The study is one of the outputs of the project under the auspices of the World Bank.

For the third time in a row we have prepared a workshop for students from Hilbert College (Buffalo, N.Y.). This year, the workshop was focused on the migration and public administration. In addition to the city sightseeing, students were able to visit the premises of the Primate's Palace and discuss with the mayor's adviser on the management of the office. We are looking forward to the next year!

Peter Pažitný a Daniela Kandilaki were awarded by the Dean of the Faculty of management at University of Economics (3rd place) for the best publication in the field of "Management" in 2017.  The Dean of Faculty, Mr. Vladislav BÍna appreciated their co-authorship in the publication Health Systems in Transition: Slovakia.

Ribera Salud acquired a 34% stake in Pro Diagnostic Group, a.s. in October 2017. During the acquisition process it relied on strategic advice, analytical services, and communication support from our team. Ribera Salud is the leading healthcare provider in Spain and the author of an innovative model of integrated healthcare provision so called "Alzira model". The shareholders of this international group are Banco Sabadell (50%) and Centene Corporation (50%) which ranked No 19 on the Fortune list of top companies that are changing the world. The acquisition of the largest provider of radiological services in Slovakia, operating diagnostic centers with modalities such as magnetic resonance, CT, USG and PET / CT, is the first strategic step for Ribera Salud when entering the Slovak market. We are looking forward to o a successful cooperation!

In March 2017, we completed strategic consulting for the private dental clinic Schill Dental Clinic, which resulted in the opening of a new clinic in Košice and the relocation of a Prague office to completely new premises. Strategic cooperation was focused on the growth of its own network of dental clinics in new locations in Slovakia as well as in the Czech Republic.